HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Hepatitis C virus E1 protein
has been sequenced
Also Known As:
E1 protein, Hepatitis C virus; E1 glycoprotein, Hepatitis C virus; E1 protein, HCV; glycoprotein E1, Hepatitis C virus
Networked:
2
relevant articles (
1
outcomes,
0
trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Carbohydrates: 22023
Glycoconjugates: 1353
Glycoproteins: 24834
Membrane Glycoproteins: 2252
Viral Envelope Proteins: 291
Hepatitis C virus E1 protein: 2
Amino Acids, Peptides, and Proteins: 1
Proteins: 484843
Glycoproteins: 24834
Membrane Glycoproteins: 2252
Viral Envelope Proteins: 291
Hepatitis C virus E1 protein: 2
Membrane Proteins: 10078
Membrane Glycoproteins: 2252
Viral Envelope Proteins: 291
Hepatitis C virus E1 protein: 2
Viral Proteins: 4250
Viral Structural Proteins: 171
Viral Envelope Proteins: 291
Hepatitis C virus E1 protein: 2
Experts
1.
Kaul, Rajeev
: 1 article (01/2017)
2.
Khera, Lohit
: 1 article (01/2017)
3.
Paul, Catherine
: 1 article (01/2017)
Related Diseases
1.
Chronic Hepatitis C
07/01/1996 - "
Here, we analyzed the T cell response to peptides from hepatitis C virus E1 protein in untreated and interferon-treated patients with chronic hepatitis C virus infection.
"
07/01/1996 - "
Production of interleukin-2 in response to synthetic peptides from hepatitis C virus E1 protein in patients with chronic hepatitis C: relationship with the response to interferon treatment.
"
07/01/1996 - "
We used thirty-six 15-mer synthetic peptides from hepatitis C virus E1 protein (genotype 1a) in a sensitive interleukin-2 production assay in two groups of controls (healthy seronegative individuals and patients with liver diseases unrelated to hepatitis C virus), and three groups of patients with chronic hepatitis C: nine patients who cleared the virus after interferon treatment (group 1), nine patients who failed to respond to the therapy (group 2) and nine previously untreated patients (group 3).
"
2.
Liver Diseases (Liver Disease)
07/01/1996 - "
We used thirty-six 15-mer synthetic peptides from hepatitis C virus E1 protein (genotype 1a) in a sensitive interleukin-2 production assay in two groups of controls (healthy seronegative individuals and patients with liver diseases unrelated to hepatitis C virus), and three groups of patients with chronic hepatitis C: nine patients who cleared the virus after interferon treatment (group 1), nine patients who failed to respond to the therapy (group 2) and nine previously untreated patients (group 3).
"
3.
Virus Diseases (Viral Diseases)
07/01/1996 - "
Here, we analyzed the T cell response to peptides from hepatitis C virus E1 protein in untreated and interferon-treated patients with chronic hepatitis C virus infection.
"
4.
Neoplasm Metastasis (Metastasis)
01/01/2017 - "
Hepatitis C Virus E1 protein promotes cell migration and invasion by modulating cellular metastasis suppressor Nm23-H1.
"
Related Drugs and Biologics
1.
Peptides (Polypeptides)
2.
Interleukin-2 (IL2)
3.
Interferons